| Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density J Chen, D Pee, R Ayyagari, B Graubard, C Schairer, C Byrne, J Benichou, ... Journal of the National Cancer Institute 98 (17), 1215-1226, 2006 | 431 | 2006 |
| Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments A Achiron, Y Barak, M Gail, M Mandel, D Pee, R Ayyagari, Z Rotstein Breast cancer research and treatment 89, 265-270, 2005 | 104 | 2005 |
| Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease DO Claassen, B Carroll, LM De Boer, E Wu, R Ayyagari, S Gandhi, ... Journal of clinical movement disorders 4, 1-11, 2017 | 88 | 2017 |
| Health care burden of bronchopulmonary dysplasia among extremely preterm infants ME Mowitz, R Ayyagari, W Gao, J Zhao, A Mangili, SP Sarda Frontiers in Pediatrics 7, 510, 2019 | 55 | 2019 |
| Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison A Joseph, R Ayyagari, M Xie, S Cai, J Xie, M Huss, V Sikirica European child & adolescent psychiatry 26, 875-897, 2017 | 45 | 2017 |
| Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment R Ayyagari, W Wei, D Cheng, C Pan, J Signorovitch, EQ Wu Value in Health 18 (2), 198-205, 2015 | 44 | 2015 |
| Systematic literature review of DPP-4 inhibitors in patients with type 2 diabetes mellitus and renal impairment MC Thomas, PM Paldánius, R Ayyagari, SH Ong, PH Groop Diabetes Therapy 7, 439-454, 2016 | 39 | 2016 |
| Indirect comparison of darolutamide versus apalutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer S Halabi, S Jiang, E Terasawa, V Garcia-Horton, R Ayyagari, AR Waldeck, ... The Journal of Urology 206 (2), 298-307, 2021 | 34 | 2021 |
| Major molecular response during the first year of dasatinib, imatinib or nilotinib treatment for newly diagnosed chronic myeloid leukemia: a network meta-analysis J Signorovitch, R Ayyagari, WM Reichmann, EQ Wu, L Chen Cancer treatment reviews 40 (2), 285-292, 2014 | 32 | 2014 |
| Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis V Bonthapally, H Yang, R Ayyagari, RD Tan, S Cai, E Wu, A Gautam, ... Current medical research and opinion 31 (7), 1377-1389, 2015 | 27 | 2015 |
| Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome B Lacy, R Ayyagari, A Guerin, A Lopez, S Shi, M Luo Therapeutic Advances in Gastroenterology 12, 1756284818818326, 2019 | 23 | 2019 |
| Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine MT Driessen, JM Cohen, SF Thompson, O Patterson-Lomba, ... The Journal of Headache and Pain 23 (1), 56, 2022 | 21 | 2022 |
| Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia SN Caroff, F Mu, R Ayyagari, T Schilling, V Abler, B Carroll BMC psychiatry 18, 1-13, 2018 | 21 | 2018 |
| Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis O Patterson-Lomba, R Ayyagari, B Carroll BMC neurology 19, 1-10, 2019 | 20 | 2019 |
| Dupilumab versus cyclosporine for the treatment of moderate-to-severe atopic dermatitis in adults: indirect comparison using the eczema area and severity index LFM Ariens, A Gadkari, H van Os-Medendorp, R Ayyagari, E Terasawa, ... Acta Dermato-Venereologica 99 (10), 851-857, 2019 | 20 | 2019 |
| Pulse pressure and stroke risk: development and validation of a new stroke risk model R Ayyagari, F Vekeman, P Lefebvre, SH Ong, E Faust, A Trahey, ... Current medical research and opinion 30 (12), 2453-2460, 2014 | 20 | 2014 |
| A fourier analysis-based approach to learn classifier from distributed heterogeneous data B Park, R Ayyagari, H Kargupta Proceedings of SDM’01, 2001 | 20 | 2001 |
| Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive … R Ayyagari, D Tang, O Patterson-Lomba, Z Zhou, J Xie, D Chandiwana, ... Current medical research and opinion 34 (9), 1645-1652, 2018 | 19 | 2018 |
| A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care GS Sawicki, R Ayyagari, J Zhang, JE Signorovitch, L Fan, E Swallow, ... Pediatric Pulmonology 48 (10), 954-961, 2013 | 18 | 2013 |
| Comparing the cost of treatment with octreotide long-acting release versus lanreotide in patients with metastatic gastrointestinal neuroendocrine tumors R Ayyagari, M Neary, S Li, A Rokito, H Yang, J Xie, AB Benson III American health & drug benefits 10 (8), 408, 2017 | 17 | 2017 |
